SELLAS Life Sciences (SLS) Deferred Taxes (2013 - 2019)
SELLAS Life Sciences (SLS) reported Deferred Taxes of -$95000.0 for Q4 2019, up 93.04% year-over-year from -$49212.5 in Q4 2018, and up 93.04% quarter-over-quarter from -$1.4 million in Q4 2018.
SELLAS Life Sciences (SLS) Deferred Taxes (2013 - 2019) Analysis & Trends
SELLAS Life Sciences (SLS) has 4 years of Deferred Taxes data on file, last reported at -$95000.0 in Q4 2019.
- Deferred Taxes for Q4 2019 came in at -$95000.0, up 93.04% year-over-year; the trailing twelve-month figure through Dec 2019 was -$1.5 million (down 7.04% YoY), and the FY2021 annual result was -$239000.0, down 939.13% from the prior year.
- Deferred Taxes climbed to -$95000.0 in Q4 2019 per SLS's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $1000.0 in Q3 2017 and troughed at -$1.4 million in Q4 2018.
- A 3-year average of -$486333.3 and a median of -$95000.0 in 2019 frame the typical range for Deferred Taxes.
- On a YoY basis, Deferred Taxes climbed as much as 93.04% in 2019 and fell as far as 93.04% in 2019.
- A 3-year view of Deferred Taxes shows it stood at $1000.0 in 2017, then plunged by 136600.0% to -$1.4 million in 2018, then jumped by 93.04% to -$95000.0 in 2019.
- Business Quant data shows SLS's Deferred Taxes at -$95000.0 in Q4 2019, -$1.4 million in Q4 2018, and $1000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -95,000.00 |
| Dec 31, 2018 | -1.37 Mn |
| Sep 30, 2017 | 1,000.00 |
| Dec 31, 2013 | 1.12 Mn |
| Sep 30, 2013 | 1.16 Mn |
| Jun 30, 2013 | 1.54 Mn |
| Mar 31, 2013 | -2.76 Mn |